Eocene (EOCN)
Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company dev...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Eocene Analyst Rating
View moreForecast & Rating
Sep 9, 2026Price forecast
--100.00%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Sep 14 at 09:06 PM
12 Health Care Stocks Moving In Monday's After-Market Session
- prnewswire · Sep 9 at 11:30 AM
Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation
- PUBT · Sep 8 at 10:09 AM
Galmed regains Nasdaq compliance with $1 minimum bid price rule
- Tip Ranks · Sep 3 at 11:30 PM
Galmed Pharmaceuticals Shareholders Approve All Proposals at September 3 AGM
- PUBT · Sep 3 at 08:10 PM
Galmed Pharmaceuticals holds annual shareholder meeting
